Respiratory syncytial virus
Clinical trials for Respiratory syncytial virus explained in plain language.
Never miss a new study
Get alerted when new Respiratory syncytial virus trials appear
Sign up with your email to follow new studies for Respiratory syncytial virus, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One shot, two viruses: vaccine aims to shield older adults from RSV and HMPV
Vaccine Recruiting nowResearchers are testing a single injection vaccine designed to protect adults 60 and older from two respiratory viruses: RSV and HMPV. The trial plans to enroll about 8,000 participants who will randomly receive either the vaccine or a placebo. Scientists will track who develops …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS
Phase 2 • Sponsor: Sanofi • Aim: Vaccine
Last updated Sep 18, 2026 00:00 UTC
-
Beyfortus safety watch: 3,000 korean kids monitored for RSV protection
Prevention Recruiting nowThis study tracks the safety of Beyfortus (Nirsevimab) in up to 3,000 Korean children under 24 months who receive the shot to prevent RSV. Researchers will monitor for side effects and serious events over 180 days. It is a real-world safety check, not a test of how well it works.
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS
Sponsor: Sanofi • Aim: Prevention
Last updated Jun 27, 2026 08:00 UTC